*By Jacqueline Corba*
BODY: Shares of DocuSign surged 37 percent in the their market debut Friday. The electronic signature company raised $629 million in its initial public offering and ended the day with a market value of nearly $6 billion.
"The reception we've received on Wall Street has been great," said the DocuSign CEO Dan Springer. "The company has the scale, we have over 500 million dollars of revenue. The company continues to have great growth."
In fiscal 2018, DocuSign became cash-flow positive and generated $518 million in revenue.
Springer said the company is looking toward international expansion. Only 17 percent of the firm's revenue is from outside of the U.S.
For the full interview, [click here](https://cheddar.com/videos/docusign-ceo-dan-springer-on-first-day-of-trading).
Teva Pharmaceuticals saw shares rise during Thursday's session after announcing its growth strategy. Richard Francis, president and CEO of Teva Pharmaceuticals, joined Cheddar News to discuss its pipeline of products that the company expects to help revenue.
Brian Jacobsen, chief economist with Annex Wealth Management, joined Cheddar News to discuss the positive sessions for the stock market as investors were optimistic of a debt ceiling deal ahead of the June 1 deadline.
The Walt Disney Co. says it's scrapping plans to build a new campus in central Florida and relocate 2,000 employees from Southern California to work in digital technology, finance and product development.
